A 70-Gene Signature for Predicting Treatment Outcome in Advanced-Stage Cervical Cancer

Cervical cancer is the fourth most common cancer in women worldwide. The current approaches still have limitations in predicting the therapy outcome of each individual because of cancer heterogeneity. The goal of this study was to establish a gene expression signature that could help when choosing t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Oncolytics
Autors principals: Nguyen, Ngoc Ngo Yen, Choi, Tae Gyu, Kim, Jieun, Jung, Min Hyung, Ko, Seok Hoon, Shin, Yoonhwa, Kang, Insug, Ha, Joohun, Kim, Sung Soo, Jo, Yong Hwa
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7530249/
https://ncbi.nlm.nih.gov/pubmed/33024818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.09.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars